Human Endostatin PharmaGenie ELISA Kit (SBRS0528)

Endostatin, a C-terminal collagen XVIII fragment and potent endogenous angiogenesis inhibitor, can be quantitatively measured using the Assay Genie Human Endostatin PharmaGenie ELISA Kit. This research-use-only immunoassay supports studies in oncology, tumor biology, and vascular endothelial regulation where endostatin dynamics are linked to neovascularization, tumor progression, and anti-angiogenic therapeutic development.

Validated for cell culture supernatants and human blood-derived samples, the kit accommodates both cell-based experiments and translational research workflows. Each kit provides reagents for 96 individual assays, making it practical for screening multiple experimental conditions, time-course studies, or comparative analyses across treatment groups.

Researchers investigating cancer biomarkers, the molecular pathways controlling tumor growth and metastasis, or the regulation of angiogenic balance will find this ELISA kit a reliable tool for measuring circulating endostatin concentrations with reproducibility across experimental runs.